Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Lymphoid Cells and Tissues01:18

Lymphoid Cells and Tissues

1.2K
Lymphoid cells and tissues are integral to the immune system, which is crucial in maintaining our body's defense against harmful pathogens. They form the building blocks of lymphoid organs, which include the spleen, thymus, and lymph nodes.
Lymphoid cells consist of various types of immune system cells. These include B and T lymphocytes, which are responsible for producing antibodies and killing infected cells, respectively. Dendritic cells act as messengers between the innate and adaptive...
1.2K
Lymphatic Vessels and Lymph Transport01:16

Lymphatic Vessels and Lymph Transport

3.7K
Lymphatic vessels, known as lymphatics, are crucial in transporting lymph from peripheral tissues to our venous system. This process begins with lymph entering through tiny capillaries that branch through tissues. These capillaries have unique features such as larger diameters, thinner walls, and a distinctive one-way valve system formed by overlapping endothelial cells.
This one-way system allows fluids, solutes, and even pathogens to enter but prevents their return to the intercellular...
3.7K
Primary Lymphoid Organs01:16

Primary Lymphoid Organs

1.6K
Primary lymphoid organs are pivotal in the formation, development, and maturation of lymphocytes, the white blood cells that serve as the backbone of our immune system. This crucial function underscores their fundamental role in maintaining our overall health and immunity. The two primary lymphoid organs of prime importance are the red bone marrow and the thymus.
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...
1.6K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Secondary Lymphoid Organs01:15

Secondary Lymphoid Organs

1.6K
Secondary organs, including lymph nodes, the spleen, and mucosa-associated lymphoid tissue (MALT), work harmoniously to protect us from disease and infection.
The spleen is a vital organ in the lymphatic system, nestled in the upper left side of the abdomen. It is composed of two primary regions: the red pulp and the white pulp, each having distinct functions. The red pulp performs a significant role in blood filtration. It efficiently purges the blood of old or damaged red blood cells and...
1.6K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Ibrutinib plus venetoclax for relapsed/refractory mantle cell lymphoma: Final analysis of the phase 3 SYMPATICO study.

British journal of haematology·2026
Same author

Australasian chronic lymphocytic leukaemia consensus statement: 2026 update.

Internal medicine journal·2026
Same author

High-Dose Methotrexate as CNS Prophylaxis in Ultra High-Risk Large B-Cell Lymphoma: An International Multicenter Analysis.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same author

Indirect Comparison of the Efficacy of Zanubrutinib vs Ibrutinib and Acalabrutinib in Treatment-Naive Chronic Lymphocytic Leukemia: 6-Year Follow-Up.

Advances in therapy·2026
Same author

Obinutuzumab, lenalidomide, and venetoclax for the initial treatment of patients with advanced-stage follicular lymphoma: Results of the Phase Ib/II LEVERAGE study.

HemaSphere·2026
Same author

USP2 is an androgen-repressed survival factor that stabilises oncoproteins to facilitate therapy resistance in prostate cancer.

Cell death & disease·2026

相关实验视频

Updated: Jul 15, 2025

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation
09:02

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation

Published on: November 26, 2018

21.2K

慢性淋巴细胞白血病澳大利亚的共识实践声明.

Mary A Anderson1,2,3, Rory Bennett1, Xavier Badoux4

  • 1Department of Clinical Haematology, The Royal Melbourne Hospital and The Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.

Internal medicine journal
|September 24, 2023
PubMed
概括

本共识声明为澳大利亚和新西兰的慢性淋巴细胞白血病 (CLL) 管理提供了最新的指导. 它结合了诊断方面的进步,像BTKi和BCL2抑制剂这样的新疗法,以及血液学家的流行病考虑.

关键词:
在 CLL CLL 中.一致的共识共识.诊断 诊断 诊断 诊断 诊断 诊断管理的管理管理的管理.

更多相关视频

From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia
10:18

From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia

Published on: October 19, 2014

13.8K
Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
09:57

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

Published on: March 5, 2018

29.4K

相关实验视频

Last Updated: Jul 15, 2025

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation
09:02

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation

Published on: November 26, 2018

21.2K
From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia
10:18

From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia

Published on: October 19, 2014

13.8K
Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
09:57

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

Published on: March 5, 2018

29.4K

科学领域:

  • 血液学 血液学 血液学
  • 在瘤学瘤学.
  • 医学实践 医学实践

背景情况:

  • 慢性淋巴细胞白血病 (CLL) 是澳大利亚和新西兰 (ANZ) 最常见的血液恶性瘤.
  • 最近诊断工具的进步,包括下一代测序和可测量的残留疾病评估,已经显著影响了CLL预后和反应评估.
  • 对于CLL的治疗场景已经被新型药物如布鲁顿氨酸激酶 (BTKi) 和BCL2抑制剂所彻底改变.

研究的目的:

  • 为CLL的调查和管理提供标准化,澳大利亚特有的指导.
  • 为了解决CLL不断变化的诊断和治疗模式.
  • 提供关于支持性护理和特殊考虑的建议,包括在COVID-19大流行期间.

主要方法:

  • 由ANZ CLL专家组成的多学科小组制定共识实践声明.
  • 澳大利亚亚洲地区顶级血液学机构的认可.
  • 审查和综合目前的证据和临床经验在CLL管理.

主要成果:

  • 该声明整合了新的诊断技术,以改善预后.
  • 它详细介绍了新型疗法 (BTKi,BCL2抑制剂) 对各种CLL患者群体的应用.
  • 在SARS-CoV-2流行病背景下,提供了关于支持性护理和管理CLL的指导.

结论:

  • 这一共识为管理CLL的澳大利亚和新西兰临床医生提供了必要的本地化指导.
  • 这些建议反映了CLL诊断和治疗的最新进展.
  • 鉴于澳大利亚独特的医疗保健环境,标准化的管理策略至关重要.